Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10044552HBVENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TVIS10052789HBVENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TVIS30073184HIVENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TVIS44024288HTLV-1ENSG00000169083.18protein_codingARYesNo367A0A087WUX9
P10275
TCGA Plot Options
Drug Information
GeneAR
DrugBank IDDB00367
Drug NameLevonorgestrel
Target IDBE0000132
UniProt IDP10275
Regulation Typebinder
PubMed IDs14672731; 19833195; 3139361
CitationsShields-Botella J, Duc I, Duranti E, Puccio F, Bonnet P, Delansorne R, Paris J: An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells. J Steroid Biochem Mol Biol. 2003 Nov;87(2-3):111-22.@@Freyberger A, Weimer M, Tran HS, Ahr HJ: Assessment of a recombinant androgen receptor binding assay: initial steps towards validation. Reprod Toxicol. 2010 Aug;30(1):2-8. doi: 10.1016/j.reprotox.2009.10.001. Epub 2009 Oct 13.@@Kloosterboer HJ, Vonk-Noordegraaf CA, Turpijn EW: Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Contraception. 1988 Sep;38(3):325-32.
GroupsApproved; Investigational
Direct ClassificationEstrogens and derivatives
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Pathways
PharmGKBPA450218
ChEMBLCHEMBL1389